Molecular Quality Controls Market- Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Market Overview:

The Molecular Quality Controls Market is projected to grow from USD 218.5 million in 2024 to USD 568.64 million by 2032, at a robust compound annual growth rate (CAGR) of 12.7% during the forecast period.

This market is driven by the increasing demand for advanced diagnostic tools, the rising prevalence of infectious diseases, and the growing adoption of personalized medicine. Regulatory mandates for laboratory accreditation and the need to ensure accurate and reliable diagnostic results further contribute to market expansion. Technological advancements in molecular diagnostics, such as PCR and next-generation sequencing (NGS), have spurred the need for high-quality control materials to validate testing accuracy. Additionally, the growing emphasis on precision diagnostics and the integration of AI and automation in laboratory workflows has significantly enhanced the demand for robust quality control solutions. Emerging economies are witnessing substantial growth in healthcare infrastructure and diagnostic labs, boosting market prospects. Collaborations between diagnostic companies and quality control providers have led to innovations in control materials, further supporting market growth. Furthermore, the increased focus on early disease detection and efficient diagnostic systems underscores the essential role of molecular quality controls in modern healthcare.

Market Drivers:

Advancements in Molecular Diagnostics Technology:

Technological advancements in molecular diagnostic tools, including polymerase chain reaction (PCR), next-generation sequencing (NGS), and digital PCR, are driving the demand for high-quality molecular quality control products. These cutting-edge techniques require reliable control materials to maintain testing accuracy and reproducibility. For instance, Bio-Rad Laboratories offers advanced molecular quality controls for NGS and PCR applications. Innovations in multiplex assays and automation further emphasize the importance of quality control, enabling laboratories to handle high-throughput testing efficiently.

Segments:

By Product:

Independent Controls

Instrument-Specific Controls

Polymerase Chain Reaction (PCR)

DNA Sequencing & NGS

Other Technologies

By Analyte Type:

Single-Analyte Controls

Multi-Analyte Controls

By Application:

Infectious Disease Diagnostics

Oncology Testing

Genetic Testing

Other Applications

By End User:

Diagnostic Laboratories

Hospitals

IVD Manufacturers & Contract Research Organizations

Academic & Research Institutes

Other End Users

By Geography:

North America (U.S., Canada, Mexico)

Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)

Asia Pacific (China, Japan, India, South Korea, Southeast Asia, Rest of Asia Pacific)

Latin America (Brazil, Argentina, Rest of Latin America)

Middle East & Africa (GCC Countries, South Africa, Rest of the Middle East and Africa)

Key Players:

F. Hoffmann-La Roche Ltd. (Switzerland)

Bio-Rad Laboratories, Inc. (U.S.)

Danaher Corporation (U.S.)

Thermo Fisher Scientific, Inc. (U.S.)

Randox Laboratories Ltd. (U.K.)

Abbott Laboratories (U.S.)

LGC Limited (U.K.)

Seegene Inc. (South Korea)

Microbiologics, Inc. (U.S.)

Grifols, S.A. (Spain)